StonvexLoading…
StonvexCore line items from FDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $87.93B | $87.69B | $90.16B | $93.51B |
Operating Income | $5.22B | $5.56B | $4.91B | $6.25B |
Net Income | $4.09B | $4.33B | $3.97B | $3.83B |
EPS (Diluted) | $16.81 | $17.21 | $15.48 | $14.33 |
Total Assets | $87.63B | $87.01B | $87.14B | $85.99B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.50B | $6.50B | $6.86B | $6.90B |
Free Cash Flow OCF − CapEx | $2.98B | $3.14B | $2.67B | $3.07B |
Shares Outstanding | 243.00M | 251.00M | 256.00M | 266.00M |